Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Intravenous and Arterial Treatments for Acute Ischemic Stroke

Intravenous and Arterial Treatments for Acute Ischemic Stroke AbstractAcute ischemic stroke continues to be a leading cause of disability in adults and the fifth leading cause of mortality worldwide. In the past few years, acute ischemic stroke diagnosis and management has advanced by leaps and bounds, with the lengthening of the time window for intravenous tissue plasminogen activator and the establishment of endovascular stroke therapy. As a result of these changes, the focus today has shifted from proving efficacy to expanding indications and identifying all patients who may benefit from these therapies. In this pursuit, neuroimaging will continue to play a pivotal role, by shifting treatment paradigms from time-based to tissue-based. The quest to accurately determine the volume and function of salvageable brain has never been more important than now. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Topics in Magnetic Resonance Imaging Wolters Kluwer Health

Intravenous and Arterial Treatments for Acute Ischemic Stroke

Download PDF
6 pages

Loading next page...
 
/lp/wolters-kluwer-health/intravenous-and-arterial-treatments-for-acute-ischemic-stroke-40qRVPto9D

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
0899-3459
eISSN
1536-1004
DOI
10.1097/RMR.0000000000000125
pmid
28277463
Publisher site
See Article on Publisher Site

Abstract

AbstractAcute ischemic stroke continues to be a leading cause of disability in adults and the fifth leading cause of mortality worldwide. In the past few years, acute ischemic stroke diagnosis and management has advanced by leaps and bounds, with the lengthening of the time window for intravenous tissue plasminogen activator and the establishment of endovascular stroke therapy. As a result of these changes, the focus today has shifted from proving efficacy to expanding indications and identifying all patients who may benefit from these therapies. In this pursuit, neuroimaging will continue to play a pivotal role, by shifting treatment paradigms from time-based to tissue-based. The quest to accurately determine the volume and function of salvageable brain has never been more important than now.

Journal

Topics in Magnetic Resonance Imaging – Wolters Kluwer Health

Published: Jun 1, 2017

References

  • Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling
  • Executive summary: heart disease and stroke statistics—2016 update: a report from the American Heart Association
  • Thrombolysis with fibrinolysin in cerebral arterial occlusion
  • Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
  • Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators
  • Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset
  • Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
  • Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke
  • Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial
  • Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial
  • Benefits of stroke treatment using a mobile stroke unit compared with standard management: the BEST-MSU Study Run-In Phase
  • BEnefits of Stroke Treatment Delivered Using a Mobile Stroke Unit (BEST-MSU)
  • MR WITNESS: a Study of Intravenous Thrombolysis with Alteplase in MRI-Selected Patients (MR WITNESS)
  • Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study
  • PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism
  • Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial
  • The penumbra pivotal stroke trial safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease
  • Endovascular therapy after intravenous t-PA versus t-PA alone for stroke
  • Endovascular treatment for acute ischemic stroke
  • A trial of imaging selection and endovascular treatment for ischemic stroke
  • MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study
  • A randomized trial of intraarterial treatment for acute ischemic stroke
  • Endovascular therapy for ischemic stroke with perfusion-imaging selection
  • Randomized assessment of rapid endovascular treatment of ischemic stroke
  • Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke
  • Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score
  • Thrombectomy within 8 hours after Symptom onset in ischemic stroke
  • Endovascular therapy for stroke—it's about time
  • Trevo and Medical Management Versus Medical Management Alone in Wake Up and Late Presenting Strokes (DAWN)
  • Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3 (DEFUSE 3)
  • Collateral flow predicts response to endovascular therapy for acute ischemic stroke
  • Conventional enhancement CT: a valuable tool for evaluating pial collateral flow in acute ischemic stroke
  • CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct
  • Collateral circulation
  • Cerebral hemodynamics in ischemic cerebrovascular disease
  • Imaging evaluation of collaterals in the brain: physiology and clinical translation
  • Multiphase CT angiography: a new tool for the imaging triage of patients with acute ischemic stroke
  • Ischemic core and hypoperfusion volumes predict infarct size in SWIFT PRIME
  • Arterial spin-labeled perfusion imaging in acute ischemic stroke
  • Arterial spin labeling identifies tissue salvage and good clinical recovery after acute ischemic stroke
  • Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with Moyamoya disease